• How Smartwatches are Advancing Sleep Measurement

    Clinical Research News | Artificial intelligence (AI) is reshaping how clinical researchers study sleep, which has been tested with either simple self-reporting sleep logs or cumbersome sleep studies that take place in a lab or clinic. A new AI-driven sleep-staging framework called BIDSleep was developed at the University of Massachusetts Amherst.

    Jan 20, 2026

  • Closing the Research Gap in Africa Through Decentralized Patient Engagement and Remote Trial Models

    Clinical Research News | Africa remains one of the most important yet underleveraged regions in global drug development. The continent carries a substantial share of disease burden but contributes only a small fraction of clinical trial activity. This imbalance is not driven by scientific limitations or lack of patient interest. It reflects structural constraints that traditional site centric trial models have failed to overcome at scale.

    Jan 16, 2026

  • A Stronger, More Disciplined Future for Emerging Biopharma

    Clinical Research News | With the close of 2025 came the end of a prolonged biotech winter marked by reduced funding, massive job cuts, investor skepticism, and initial public offering slowdown. The experience, while painful, helped mature the biopharma industry with operational discipline and a new playbook for how to make the case with investors moving forward.

    Jan 13, 2026

  • New In-Ear EEG Platform Opens Door to Real-World Neurological Data Collection

    Clinical Research News | A newly FDA-cleared in-ear electroencephalogram (EEG) device could significantly alter how neurological conditions are studied, screened, and monitored outside traditional clinical settings. Paris-based Naox Technologies announced at CES 2026 in Las Vegas that its medical-grade Naox Link system has received U.S. Food and Drug Administration 510(k) clearance.

    Jan 12, 2026